CTLA4 and germinoma: Reports have indicated that monotherapy with PD-1 monoclonal antibodies in germinoma patients, as well as combination therapy with PD-1 and CTLA-4 monoclonal antibodies in CNS NGGCT patients, both demonstrated some therapeutic efficacy (27, 47).